Cargando…
Host deficiency in ephrin-A1 inhibits breast cancer metastasis
Background: The conventional dogma of treating cancer by focusing on the elimination of tumor cells has been recently refined to include consideration of the tumor microenvironment, which includes host stromal cells. Ephrin-A1, a cell surface protein involved in adhesion and migration, has been show...
Autores principales: | Shiuan, Eileen, Inala, Ashwin, Wang, Shan, Song, Wenqiang, Youngblood, Victoria, Chen, Jin, Brantley-Sieders, Dana M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194498/ https://www.ncbi.nlm.nih.gov/pubmed/32399207 http://dx.doi.org/10.12688/f1000research.22689.2 |
Ejemplares similares
-
Oncogenic Functions and Therapeutic Targeting of EphA2 in Cancer
por: Wilson, Kalin, et al.
Publicado: (2021) -
Eph/Ephrin Profiling in Human Breast Cancer Reveals Significant Associations between Expression Level and Clinical Outcome
por: Brantley-Sieders, Dana M., et al.
Publicado: (2011) -
VAMP-Associated Protein B (VAPB) Promotes Breast Tumor Growth by Modulation of Akt Activity
por: Rao, Meghana, et al.
Publicado: (2012) -
Eph receptors in breast cancer: roles in tumor promotion and tumor suppression
por: Vaught, David, et al.
Publicado: (2008) -
Targeting EphA2 impairs cell cycle progression and growth of basal-like/triple-negative breast cancers
por: Song, W, et al.
Publicado: (2017)